Logiscreen

Mineralys Therapeutics Inc

$23.69
Market Cap 1.95B
ROE -27.9%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 44.3
Revenue QoQ 0.0%
EPS QoQ -0.4%
F-Score 2

About

Mineralys Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-13.60
vs median 31.50
P/B
3.23
vs median 2.17
ROE
-0.28
vs median 0.09

Lower quality - review fundamentals carefully

Mid-cap company with growth potential

Similar companies

PHVSTRILKODELVNRXRXBCRX
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics